PHARMACEUTICAL SECTOR IN PAKISTAN
Pakistan meets 80% of its domestic demand of medicines from local production and 20% through imports. The pharmaceuticals market size is Rs. 70 Billion (US $ 1.2 Billion), approximately. The market for pharmaceuticals in Pakistan has been expanding at a rate of around 10 to15% since last few years.
Pakistan is also exporting its surplus drugs to a large number of countries particularly to the Asian and African regions with an expanding trade in the newly emerged Central Asian States. About a hundred million strong populations of the Central Asian States, with almost no local manufacture of medicines, offers an attractive market for industries located in Pakistan.
Pakistan’s large population of more than 140 million people, expanding economy including health services, individual rise in purchasing power, general awareness regarding use of new molecules of drugs, etc. provides an ideal environment for investment in this field.
Presently the pharmaceutical industry in Pakistan is producing all the major pharmaceutical dosage forms. Similarly, there are some special products e.g. immunological, anti-cancer drugs, certain anti-diabetics, antidotes and products manufactured from biotechnology, which are still being imported, in the finished form. These specific areas provide excellent opportunities for investment. Only few bulk pharmaceutical raw materials are being manufactured locally and most of the pharmaceutical raw materials are being imported in large quantities from different countries of the world. This sector also gives challenge to explore and avail the opportunities.
BASIC MANUFACTURE
There are five units operating in Pakistan for the Semi Basic Manufacturing of pharmaceutical raw material and still Pakistan has the capacity to absorb the significant investment in this field.
Multi National Manufacturers
At present 30 multinational pharmaceutical organizations are producing their products in Pakistan.
Local Manufacturers
411 units are involved in local pharmaceutical manufacturing.
Pharmaceutical Sector in Pakistan
Leading 20 Therapeutic Classes Contribution in %
| Cephalosporin’s & Combinations | 7.39 |
| Ant rheumatic Non Steroid | 5.62 |
| Broad Spectrum Penicillin | 5.35 |
| Non Narcotic Analgesic | 4.26 |
| Fluoroquinolones | 3.94 |
| Antiulcerants | 3.49 |
| Infant Formulas | 2.63 |
| Macrolides & Similar Types | 2.43 |
| Tranquilizers | 2.01 |
| Haematinics, Iron & Combs | 1.97 |
| Oral Antidiabetics | 1.87 |
| Calcium | 1.68 |
| Antihistamines Systemic | 1.64 |
| Vitamin B Complex | 1.56 |
| Expectorants | 1.32 |
| Beta Blocking Agent Plain | 1.27 |
| Antidepressants & Mood Stab | 1.27 |
| Multivitamins & Minerals | 1.25 |
| Amoebicides | 1.24 |
| Interferon’s | 1.18 |
| Others | 46.63 |
Biofar Chemicals offers :
We are offering mention services to Pakistan Pharmaceutical industry & the marketing companies under the strong support from our world renowned suppliers:
- Biotechnology finished Medicines
- Active Pharmaceutical Ingredients with / with out Formulation guidelines.
- Non infringing Active Pharmaceutical ingredients
- Drug Delivery solutions Neutraceutical & Ayurvedic
- Medical disposable Surgical products
- Neutraceutical & Ayurvedic
- Contract Manufacturing for local & foreign companies
Biotechnology finished Medicines
Three hundred and twenty-four new medicines and vaccines developed through biotechnology are now being tested to treat nearly 150 diseases, according to a new survey of biotechnology medicines released by the Pharmaceutical Research and Manufacturers of America (PhRMA). All of the new biotechnology medicines and vaccines are now in clinical trails or awaiting approval from the U.S. Food and Drug Administration (FDA).
The survey found that the new biotechnology medicines include 154 medicines to treat cancer, 43 to treat infectious disease, 26 to treat autoimmune disorders, 16 to treat neurological disorders and 17 to treat HIV/AIDS and related-conditions.
Every year, more and more patients benefit from long, expensive and intense research into the human genome and the molecular basis of disease. These new medicines along with those now in the pipeline are fundamentally changing the way we fight disease.”
- The survey released finds that the new biotechnology medicines in development include: An epidermal growth factor inhibitor for lung cancer.
- Monoclonal antibodies that target asthma, Crohn’s disease, rheumatoid arthritis, lupus and cancer.
- Therapeutic vaccines designed to jump-start the immune system to fight diseases such as AIDS and cancer.
- Antisense products as potential treatments for AIDS, cancer and heart disease.
- Gene therapy testing in cancer, cystic fibrosis and heart disease.
More than 250 million patients have benefited from already approved biotechnology medicines to treat or prevent heart attacks, stroke, multiple sclerosis, leukemia, hepatitis, rheumatoid arthritis, breast cancer, diabetes, congestive heart failure, kidney cancer, cystic fibrosis and other diseases.
While considering above facts Biofar Chemicals can offer you those products which are already developed and their patent are also expired & it’s freely available in country of origin & can be marketed in Pakistan.
Medical Disposable Surgical products
- Urology
- Anesthesia
- Surgery
- Gastroenterology
- Transfusion
Active Pharmaceutical Ingredients with / with out Formulation guidelines
- Alimentary Tract & Metabolism
- Blood & Blood forming organs
- Cardiovascular System
- Dermatological Products
- Genito Urinary & Sex Hormones
- Hormones Without Sex Hormones
- Anti Infective System
- Hospital Solutions
- Cytostatic
- Musculoskeletal System
- Central Nervous System
- Parasitology
- Respiratory System
- Sensory Organs
Non infringing Active Pharmaceutical ingredients
- Alimentary Tract & Metabolism
- Blood & Blood forming organs
- Cardiovascular System
- Dermatological Products
- Genito Urinary & Sex Hormones
- Hormones Without Sex Hormones
- Anti Infective System
- Hospital Solutions
- Cytostatic
- Musculoskeletal System
- Central Nervous System
- Parasitology
- Respiratory System
- Sensory Organs
Neutraceuitcal products
The last couple of decades witnessed phenomenal increase of Neutraceuticals use world wide. Today Neutraceuticals is over USD 80 Billion market with an increasing trend both in both at prescription and OTC level since highly profile companies are shifting to this area.
Biofar Chemicals can offer you from our most reliable suppliers in the mention area:
- Formulated products
- Food Supplement
- Personal Care
- Pure Herbs